Welcome to the CCIO: Clinical Conundrums in Immuno-Oncology Self-learning Platform!
This innovative self-learning program is designed to tackle the most complex questions surrounding the management of oncology patients. Immerse yourself in a world of knowledge as a multi-disciplinary panel of experts come together to share their insights and experiences. Delve into concise and practical video vignettes, carefully curated to cater to your unique learning needs.
With its flexible format, CCIO adapts to your schedule, allowing you to learn at your own pace!
Program objectives
After participating in this program on bladder, kidney, lung, skin, and upper gastrointestinal (uGI) cancers, participants will be better able to:
- Discuss clinical questions and key data regarding the appropriate use of immuno-oncology (I-O) in both early and advanced stages
- Implement best practices and multidisciplinary approaches to optimize outcomes for patients
- Identify and manage immune-related adverse events (irAEs) in clinical practice
STEERING COMMITTEE
Barbara Melosky, MD, FRCPC (Chair)
Professor of Medicine, University of British Columbia
Vancouver, British Columbia
Kevin Jao, MD, PhD
Hôpital du Sacré-Cœur-de-Montréal
Montréal, Québec
Aly-Khan Lalani, BSc (Hons), MD, FRCPC
Assistant Professor, McMaster University
Hamilton, Ontario
Stephanie Snow, MD, FRCPC
Medical Oncologist, QEII Health Sciences Centre
Associate Professor, Dalhousie University
President, Lung Cancer Canada
Halifax, Nova Scotia